182 related articles for article (PubMed ID: 33255304)
21. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules.
Alhamhoom Y; Ravi G; Osmani RAM; Hani U; Prakash GM
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364338
[No Abstract] [Full Text] [Related]
22. Solid lipid nanoparticles for enhanced oral absorption: A review.
Salah E; Abouelfetouh MM; Pan Y; Chen D; Xie S
Colloids Surf B Biointerfaces; 2020 Dec; 196():111305. PubMed ID: 32795844
[TBL] [Abstract][Full Text] [Related]
23. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
24. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
Patel MH; Mundada VP; Sawant KK
Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
[No Abstract] [Full Text] [Related]
25. Effect of a Solid Lipid Nanoparticle Formulation on the Bioavailability of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine After Oral Administration.
Valdes SA; Alzhrani RF; Lansakara-P DSP; Cui Z
AAPS PharmSciTech; 2020 Jan; 21(3):77. PubMed ID: 31970527
[TBL] [Abstract][Full Text] [Related]
26. Formulation and Optimization of Topical Solid Lipid Nanoparticles based Gel of Dapsone Using Design of Experiment.
Deshkar SS; Bhalerao SG; Jadhav MS; Shirolkar SV
Pharm Nanotechnol; 2018; 6(4):264-275. PubMed ID: 30394227
[TBL] [Abstract][Full Text] [Related]
27. Correlating gastric emptying of amphotericin B and paracetamol solid lipid nanoparticles with changes in particle surface chemistry.
Amekyeh H; Billa N; Roberts C
Int J Pharm; 2017 Jan; 517(1-2):42-49. PubMed ID: 27923696
[TBL] [Abstract][Full Text] [Related]
28. The design of naproxen solid lipid nanoparticles to target skin layers.
Akbari J; Saeedi M; Morteza-Semnani K; Rostamkalaei SS; Asadi M; Asare-Addo K; Nokhodchi A
Colloids Surf B Biointerfaces; 2016 Sep; 145():626-633. PubMed ID: 27288817
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers.
Lin CH; Chen CH; Lin ZC; Fang JY
J Food Drug Anal; 2017 Apr; 25(2):219-234. PubMed ID: 28911663
[TBL] [Abstract][Full Text] [Related]
30. Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis.
Musielak E; Feliczak-Guzik A; Nowak I
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408600
[TBL] [Abstract][Full Text] [Related]
31. Novel Solid Lipid Nanoparticle with Endosomal Escape Function for Oral Delivery of Insulin.
Xu Y; Zheng Y; Wu L; Zhu X; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(11):9315-9324. PubMed ID: 29484890
[TBL] [Abstract][Full Text] [Related]
32. Effect of lipids on absorption of carvedilol in dogs: Is coadministration of lipids as efficient as a lipid-based formulation?
Alskär LC; Parrow A; Keemink J; Johansson P; Abrahamsson B; Bergström CAS
J Control Release; 2019 Jun; 304():90-100. PubMed ID: 31047962
[TBL] [Abstract][Full Text] [Related]
33. Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs.
Fan T; Chen C; Guo H; Xu J; Zhang J; Zhu X; Yang Y; Zhou Z; Li L; Huang Y
Eur J Pharm Biopharm; 2014 Oct; 88(2):518-28. PubMed ID: 24968819
[TBL] [Abstract][Full Text] [Related]
34. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
35. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition.
Shah P; Chavda K; Vyas B; Patel S
Drug Deliv Transl Res; 2021 Jun; 11(3):1166-1185. PubMed ID: 32804301
[TBL] [Abstract][Full Text] [Related]
36. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
Zafar A
J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of the effectiveness of lipid nanoparticle formulations loaded with anti-tubercular drugs combinations toward overcoming drug bioavailability in tuberculosis.
Banerjee S; Roy S; Bhaumik KN; Pillai J
J Drug Target; 2020 Jan; 28(1):55-69. PubMed ID: 31035816
[TBL] [Abstract][Full Text] [Related]
38. Development of Lipid-Based Nanocarriers for Increasing Gastrointestinal Absorption of Lupinifolin.
Musika J; Chudapongse N
Planta Med; 2020 Mar; 86(5):364-372. PubMed ID: 32005042
[TBL] [Abstract][Full Text] [Related]
39. Fabrication of solid lipid nanoparticles-based patches of paroxetine and their
Pervaiz F; Saba A; Yasin H; Buabeid M; Noreen S; Khan AK; Murtaza G
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):108-119. PubMed ID: 36855254
[TBL] [Abstract][Full Text] [Related]
40. Polyester-Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel.
Gou J; Feng S; Liang Y; Fang G; Zhang H; Yin T; Zhang Y; He H; Wang Y; Tang X
Mol Pharm; 2017 Nov; 14(11):3750-3761. PubMed ID: 28945434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
